Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder

ClinicalTrials.gov ID: NCT06878976

Public ClinicalTrials.gov record NCT06878976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label and Double-Blind, Randomized Withdrawal Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Adults With Binge Eating Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, multi-center, open-label and randomized withdrawal study to evaluate the long-term safety and efficacy of solriamfetol in the treatment of binge eating disorder (BED) in adults.

Study identification

NCT ID
NCT06878976
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
236 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 56 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2025 (Actual)
Primary completion
Dec 2027 (Estimated)
Completion
Dec 2027 (Estimated)
Last update posted
Aug 11, 2026

2025 – 2027

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Clinical Research Site Encino California 91316 —
Clinical Research Site Long Beach California 90806 —
Clinical Research Site Santa Ana California 92705 —
Clinical Research Site Walnut Creek California 94596 —
Clinical Research Site West Covina California 91790 —
Clinical Research Site Cromwell Connecticut 06416 —
Clinical Research Site Fort Myers Florida 33912 —
Clinical Research Site Jacksonville Florida 32256 —
Clinical Research Site Lauderhill Florida 33319 —
Clinical Research Site Miami Florida 33145 —
Clinical Research Site Miami Florida 33176 —
Clinical Research Site Miami Lakes Florida 33016 —
Clinical Research Site Orlando Florida 32801 —
Clinical Research Site Marietta Georgia 30060 —
Clinical Research Site Overland Park Kansas 66210 —
Clinical Research Site Boston Massachusetts 02131 —
Clinical Research Site Saint Charles Missouri 63304 —
Clinical Research Site Cherry Hill New Jersey 08002 —
Clinical Research Site Mount Kisco New York 10549 —
Clinical Research Site New York New York 10128 —
Clinical Research Site Raleigh North Carolina 27607 —
Clinical Research Site Cincinnati Ohio 45215 —
Clinical Research Site Mason Ohio 45040 —
Clinical Research Site Middleburg Heights Ohio 44130 —
Clinical Research Site North Canton Ohio 44720 —
Clinical Research Site Portland Oregon 97210 —
Clinical Research Site Allentown Pennsylvania 18103 —
Clinical Research Site North Charleston South Carolina 29405 —
Clinical Research Site Memphis Tennessee 38119 —
Clinical Research Site Austin Texas 78731 —
Clinical Research Site Austin Texas 78737 —
Clinical Research Site Dallas Texas 75251 —
Clinical Research Site San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06878976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2026 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06878976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →